Delivery Order SPE2DB22D3016-SPE2DB25FBEU4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Valtoco 10 mg nasal spray, a medication used in emergency seizure management. This competitively awarded, non-set-aside firm fixed price delivery order carries a ceiling value of $1,129.62 and is scheduled for completion by August 12, 2025. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Valtoco 15 mg nasal sprays, a medication used for acute seizure management. This competitively awarded, firm fixed-price delivery order has a ceiling value of $4,373.64 and an ultimate completion date of August 11, 2025. The contract is not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,185.90 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, a medication used in emergency treatment of seizure clusters. The competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a non-set-aside procurement, reflecting...
- The Defense Logistics Agency awarded a $2,093.98 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This firm fixed-price contract was competitively awarded without set-aside designations and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Valtoco 15 mg nasal spray, a medication indicated for acute seizure management. This firm fixed-price delivery order, valued at $1,128.54, represents a non-competitive set-aside and is scheduled for completion by August 4, 2025. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Valtoco 10 mg nasal spray, a seizure rescue medication. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,784.67 and is scheduled for completion by August 4, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, valued at $2,257.08 under firm fixed pricing. This delivery order, issued on July 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,126.10 for Valtoco 5 mg nasal sprays, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEU4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, a medication used for acute seizure treatment. This competitive, firm fixed-price delivery order, valued at $4,685.26, was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. The company's federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/12/25 |